I think it says before Sep-10 in a report put out during the rights issue late last year. Im guessing its in the bag pending more good results from their current trials of the new Vitrogro in the UK and here. They have banged on in the past about an agreement just needing more results. So they most likely have a very short short list or partners but just need to give those guys greater confidence that no ones going to grow three asses after a Vitrogro treatment.
Thats why I reckon we'll get a very good snowball run-up in Q1+Q2 this year as each new development(announcement) feeds off each other.
Snapping
TIS Price at posting:
19.3¢ Sentiment: LT Buy Disclosure: Held
